BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vinhas R, Fernandes AR, Baptista PV. Gold Nanoparticles for BCR-ABL1 Gene Silencing: Improving Tyrosine Kinase Inhibitor Efficacy in Chronic Myeloid Leukemia. Mol Ther Nucleic Acids 2017;7:408-16. [PMID: 28624216 DOI: 10.1016/j.omtn.2017.05.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
Number Citing Articles
1 Sun Y, Zhao Y, Zhao X, Lee RJ, Teng L, Zhou C. Enhancing the Therapeutic Delivery of Oligonucleotides by Chemical Modification and Nanoparticle Encapsulation. Molecules 2017;22:E1724. [PMID: 29027965 DOI: 10.3390/molecules22101724] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
2 Svahn N, Moro AJ, Roma-rodrigues C, Puttreddy R, Rissanen K, Baptista PV, Fernandes AR, Lima JC, Rodríguez L. The Important Role of the Nuclearity, Rigidity, and Solubility of Phosphane Ligands in the Biological Activity of Gold(I) Complexes. Chem Eur J 2018;24:14654-67. [DOI: 10.1002/chem.201802547] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 4.8] [Reference Citation Analysis]
3 Jindal M, Nagpal M, Singh M, Aggarwal G, Dhingra GA. Gold Nanoparticles- Boon in Cancer Theranostics. Curr Pharm Des 2020;26:5134-51. [PMID: 32611300 DOI: 10.2174/1381612826666200701151403] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Remant KC, Thapa B, Valencia-Serna J, Domun SS, Dimitroff C, Jiang X, Uludağ H. Cholesterol grafted cationic lipopolymers: Potential siRNA carriers for selective chronic myeloid leukemia therapy. J Biomed Mater Res A 2020;108:565-80. [PMID: 31714657 DOI: 10.1002/jbm.a.36837] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
5 Ferreira D, Fontinha D, Martins C, Pires D, Fernandes AR, Baptista PV. Gold Nanoparticles for Vectorization of Nucleic Acids for Cancer Therapeutics. Molecules 2020;25:E3489. [PMID: 32751935 DOI: 10.3390/molecules25153489] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Khalil AT, Ovais M, Iqbal J, Ali A, Ayaz M, Abbas M, Ahmad I, Devkota HP. Microbes-mediated synthesis strategies of metal nanoparticles and their potential role in cancer therapeutics. Semin Cancer Biol 2021:S1044-579X(21)00176-0. [PMID: 34118405 DOI: 10.1016/j.semcancer.2021.06.006] [Reference Citation Analysis]
7 Kc R, Thapa B, Ubeda A, Jiang X, Uludağ H. BCR-Abl Silencing by siRNA: A Potent Approach to Sensitize Chronic Myeloid Leukemia Cells to Tyrosine Kinase Inhibitor Therapy. Stem Cells Dev 2019;28:734-44. [PMID: 30585758 DOI: 10.1089/scd.2018.0196] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
8 Ercaliskan A, Eskazan AE. The impact of BCR-ABL1 transcript type on tyrosine kinase inhibitor responses and outcomes in patients with chronic myeloid leukemia: Impact of Transcript Type on TKI Outcomes in CML. Cancer 2018;124:3806-18. [DOI: 10.1002/cncr.31408] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
9 Vinhas R, Mendes R, Fernandes AR, Baptista PV. Nanoparticles-Emerging Potential for Managing Leukemia and Lymphoma. Front Bioeng Biotechnol. 2017;5:79. [PMID: 29326927 DOI: 10.3389/fbioe.2017.00079] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
10 Limongi T, Susa F, Cauda V. Nanoparticles for hematologic diseases detection and treatment. Hematol Med Oncol 2019;4:1000183. [PMID: 33860108 DOI: 10.15761/hmo.1000183] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Fialho L, Araújo D, Alves VD, Roma-rodrigues C, Baptista PV, Fernandes AR, Freitas F, Reis MAM. Cation-mediated gelation of the fucose-rich polysaccharide FucoPol: preparation and characterization of hydrogel beads and their cytotoxicity assessment. International Journal of Polymeric Materials and Polymeric Biomaterials 2021;70:90-9. [DOI: 10.1080/00914037.2019.1695205] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Wei X, Zhang X, Guo R, Chen M, Yang T, Xu Z, Wang J. A Spiral-Helix (3D) Tubing Array That Ensures Ultrahigh-Throughput Single-Cell Sampling. Anal Chem 2019;91:15826-32. [DOI: 10.1021/acs.analchem.9b04122] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
13 Lenis-Rojas OA, Carvalho B, Cabral R, Silva M, Friães S, Roma-Rodrigues C, Meireles MSH, Gomes CSB, Fernández JAA, Vila SF, Rubiolo JA, Sanchez L, Baptista PV, Fernandes AR, Royo B. Manganese(I) tricarbonyl complexes as potential anticancer agents. J Biol Inorg Chem 2021. [PMID: 34713347 DOI: 10.1007/s00775-021-01910-7] [Reference Citation Analysis]
14 Oliveira H, Roma-Rodrigues C, Santos A, Veigas B, Brás N, Faria A, Calhau C, de Freitas V, Baptista PV, Mateus N, Fernandes AR, Fernandes I. GLUT1 and GLUT3 involvement in anthocyanin gastric transport- Nanobased targeted approach. Sci Rep 2019;9:789. [PMID: 30692585 DOI: 10.1038/s41598-018-37283-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
15 Geskovski N, Matevska-Geshkovska N, Dimchevska Sazdovska S, Glavas Dodov M, Mladenovska K, Goracinova K. The impact of molecular tumor profiling on the design strategies for targeting myeloid leukemia and EGFR/CD44-positive solid tumors. Beilstein J Nanotechnol 2021;12:375-401. [PMID: 33981532 DOI: 10.3762/bjnano.12.31] [Reference Citation Analysis]
16 Shen J, Lu Z, Wang J, Zhang T, Yang J, Li Y, Liu G, Zhang X. Advances of Nanoparticles for Leukemia Treatment. ACS Biomater Sci Eng 2020;6:6478-89. [PMID: 33320613 DOI: 10.1021/acsbiomaterials.0c01040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Palomino-vizcaino G, Alvarez-salas LM. Therapeutic Oligonucleotides Against Cancer: Recent Approaches and New Perspectives. Nucleic Acid Nanotheranostics. Elsevier; 2019. pp. 1-26. [DOI: 10.1016/b978-0-12-814470-1.00001-0] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
18 Huang L, Huang J, Huang J, Xue H, Liang Z, Wu J, Chen C. Nanomedicine - a promising therapy for hematological malignancies. Biomater Sci 2020;8:2376-93. [PMID: 32314759 DOI: 10.1039/d0bm00129e] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
19 Roma-Rodrigues C, Rivas-García L, Baptista PV, Fernandes AR. Gene Therapy in Cancer Treatment: Why Go Nano? Pharmaceutics 2020;12:E233. [PMID: 32151052 DOI: 10.3390/pharmaceutics12030233] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 14.5] [Reference Citation Analysis]
20 Carvalho A, Fernandes AR, Baptista PV. Nanoparticles as Delivery Systems in Cancer Therapy. Applications of Targeted Nano Drugs and Delivery Systems. Elsevier; 2019. pp. 257-95. [DOI: 10.1016/b978-0-12-814029-1.00010-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
21 Wan Z, Sun R, Moharil P, Chen J, Liu Y, Song X, Ao Q. Research advances in nanomedicine, immunotherapy, and combination therapy for leukemia. J Leukoc Biol 2021;109:425-36. [PMID: 33259068 DOI: 10.1002/JLB.5MR0620-063RR] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
22 Shakil MS, Niloy MS, Mahmud KM, Kamal MA, Islam MA. Theranostic Potentials of Gold Nanomaterials in Hematological Malignancies. Cancers 2022;14:3047. [DOI: 10.3390/cancers14133047] [Reference Citation Analysis]
23 Rodrigo AP, Mendes VM, Manadas B, Grosso AR, Alves de Matos AP, Baptista PV, Costa PM, Fernandes AR. Specific Antiproliferative Properties of Proteinaceous Toxin Secretions from the Marine Annelid Eulalia sp. onto Ovarian Cancer Cells. Mar Drugs 2021;19:31. [PMID: 33445445 DOI: 10.3390/md19010031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Pandey V, Ganeshpurkar A, Thakur A, Sharma M, Rajpoot K, Tekade M, Sreeharsha N, Tekade RK. Gold nanoparticles: An advanced drug delivery and diagnostic tool. The Future of Pharmaceutical Product Development and Research. Elsevier; 2020. pp. 609-69. [DOI: 10.1016/b978-0-12-814455-8.00018-9] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
25 Milán Rois P, Latorre A, Rodriguez Diaz C, Del Moral Á, Somoza Á. Reprogramming Cells for Synergistic Combination Therapy with Nanotherapeutics against Uveal Melanoma. Biomimetics (Basel) 2018;3:E28. [PMID: 31105250 DOI: 10.3390/biomimetics3040028] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
26 Jia S, Guo B, Wang L, Peng L, Zhang L. The Current Status of SSRP1 in Cancer: Tribulation and Road Ahead. J Healthc Eng 2022;2022:3528786. [PMID: 35463672 DOI: 10.1155/2022/3528786] [Reference Citation Analysis]